Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma

PURPOSE: High-dose methotrexate based chemotherapy is the standard treatment for patients with newly diagnosed primary central nervous system lymphoma (PCNSL). The role of rituximab is controversial because of its large size, which limits its penetration of the blood-brain barrier. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xuefei, Liu, Jing, Wang, Yaming, Bai, Xueyan, Chen, Yuedan, Qian, Jun, Zhu, Hong, Liu, Fusheng, Qiu, Xiaoguang, Sun, Shengjun, Ji, Nan, Liu, Yuanbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564757/
https://www.ncbi.nlm.nih.gov/pubmed/28467782
http://dx.doi.org/10.18632/oncotarget.17101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564757/
https://www.ncbi.nlm.nih.gov/pubmed/28467782
http://dx.doi.org/10.18632/oncotarget.17101

Ejemplares similares